9621
0
Posted on Feb 02, 2003, 5 a.m.
By Bill Freeman
Trials of three cannabis-based drugs have produced promising results. British drug company GW Pharmaceuticals tested its three new drugs on 34 people with multiple sclerosis, spinal cord injury, or other conditions that caused severe pain, whom had not responded well to other medications. 82% of participants said that the drugs effectively relieved pain and helped them to sleep better.
Trials of three cannabis-based drugs have produced promising results. British drug company GW Pharmaceuticals tested its three new drugs on 34 people with multiple sclerosis, spinal cord injury, or other conditions that caused severe pain, whom had not responded well to other medications. 82% of participants said that the drugs effectively relieved pain and helped them to sleep better. Study leader, Dr Willy Notcutt, said of the findings: "Given the previously intractable nature of their pain symptoms, the improvements provided by cannabis-based medicines are all the more remarkable." Meanwhile, Dr Geoffrey Guy, GW's executive chairman, said: "We are delighted with the results of this study in patients with severe pain."
SOURCE/REFERENCE: Reported by www.bbc.co.uk on the 30th September 2002
